*To be consumed as directed by physician.
Therapies:
Breast Cancer
Composition:
Leuprolide acetate for injection 11.25 mg/vail
Leuxa Depot 11.25mg injection contains Leuprolide acetate, which explains the Leuxa Depot 11.25mg composition. It belongs to a group of medicines known as Gonadotropin Releasing Hormone (GnRH) agonists. This medicine works by reducing the production of certain hormones in the body.
Doctors commonly prescribe Sun Pharma Leuxa Depot 11.25mg for hormone-dependent conditions. Its approved uses include Leuxa Depot 11.25mg for prostate cancer, hormone-responsive breast cancer, and Leuxa Depot 11.25mg in endometriosis, where uterine-like tissue grows outside the uterus and causes pain. It is also used for uterine fibroids and Leuxa Depot 11.25mg for precocious puberty in children who experience early hormonal development.
The Leuxa Depot 11.25mg injection frequency is usually once every three months, but the exact schedule is decided by the doctor based on the condition being treated and the patient’s response. Long-term treatment may affect bones, so doctors closely monitor Leuxa Depot 11.25mg and bone density, especially in women and older patients.
*To be consumed as directed by physician.
Leuxa Depot 11.25mg Injection uses are:
